1-2 of 2
Jia Luo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B159: A first-in-human study of CDK9 inhibitor KB-0742 demonstrates evidence of tolerability and clinical activity

Miguel Villalona-Calero, Monica Mita, Alain Mita, Noah Federman, Drew Rasco, David Spigel, Jia Luo, Glenn J Hanna, Gregory M Cote, Richard E Cutler, Pavan Kumar, Crystal MacKenzie, Charles Lin, Jorge F DiMartino, Elizabeth A Olek, Brian Van Tine
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12_Supplement): B159.
https://doi.org/10.1158/1535-7163.TARG-23-B159
Published: 01 December 2023
View article titled, Abstract B159: A first-in-human study of CDK9 inhibitor KB-0742 demonstrates evidence of tolerability and clinical activity
Journal Articles

Apigenin Induces Apoptosis in Human Leukemia Cells and Exhibits Anti-Leukemic Activity In Vivo

Amit Budhraja, Ning Gao, Zhuo Zhang, Young-Ok Son, Senping Cheng, Xin Wang, Songze Ding, Andrew Hitron, Gang Chen, Jia Luo, Xianglin Shi
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (1): 132–142.
https://doi.org/10.1158/1535-7163.MCT-11-0343
Published: 09 January 2012
View article titled, Apigenin Induces Apoptosis in Human Leukemia Cells and Exhibits Anti-Leukemic Activity <em>In Vivo</em>
Open the PDF for Apigenin Induces Apoptosis in Human Leukemia Cells and Exhibits Anti-Leukemic Activity <em>In Vivo</em> in another window
Includes: Supplementary data